Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP368472.RA4A2gV-8CKNqrw6Z4kAZpIWx-qH75CuioyC8Myo1aBX8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP368472.RA4A2gV-8CKNqrw6Z4kAZpIWx-qH75CuioyC8Myo1aBX8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP368472.RA4A2gV-8CKNqrw6Z4kAZpIWx-qH75CuioyC8Myo1aBX8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP368472.RA4A2gV-8CKNqrw6Z4kAZpIWx-qH75CuioyC8Myo1aBX8130_provenance.
- befree-2016 importedOn "2016-02-19" NP368472.RA4A2gV-8CKNqrw6Z4kAZpIWx-qH75CuioyC8Myo1aBX8130_provenance.
- NP368472.RA4A2gV-8CKNqrw6Z4kAZpIWx-qH75CuioyC8Myo1aBX8130_assertion wasGeneratedBy ECO_0000203 NP368472.RA4A2gV-8CKNqrw6Z4kAZpIWx-qH75CuioyC8Myo1aBX8130_provenance.
- NP368472.RA4A2gV-8CKNqrw6Z4kAZpIWx-qH75CuioyC8Myo1aBX8130_assertion wasDerivedFrom befree-2016 NP368472.RA4A2gV-8CKNqrw6Z4kAZpIWx-qH75CuioyC8Myo1aBX8130_provenance.
- NP368472.RA4A2gV-8CKNqrw6Z4kAZpIWx-qH75CuioyC8Myo1aBX8130_assertion SIO_000772 12242461 NP368472.RA4A2gV-8CKNqrw6Z4kAZpIWx-qH75CuioyC8Myo1aBX8130_provenance.
- NP368472.RA4A2gV-8CKNqrw6Z4kAZpIWx-qH75CuioyC8Myo1aBX8130_assertion evidence source_evidence_literature NP368472.RA4A2gV-8CKNqrw6Z4kAZpIWx-qH75CuioyC8Myo1aBX8130_provenance.
- NP368472.RA4A2gV-8CKNqrw6Z4kAZpIWx-qH75CuioyC8Myo1aBX8130_assertion description "[Ac-GIP and pGlu-GIP, show resistance to plasma dipeptidylpeptidase IV degradation, resulting in enhanced biological activity and improved antidiabetic potential in vivo, raising the possibility of their use in therapy of Type II (non-insulin-dependent) diabetes mellitus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP368472.RA4A2gV-8CKNqrw6Z4kAZpIWx-qH75CuioyC8Myo1aBX8130_provenance.